InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (4 ops.)
Browse the detailed record of transactions filed by Heerma Peter, Directeur Commercial. Officer active across 1 companies, notably Travere Therapeutics, Inc.. Aggregated, 8 disclosures have been logged. Total volume traded: €213k. The latest transaction was disclosed on 31 January 2022 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Declarations8 total
09,840 shares0
Common Stock
SEC:0001209191-22-006363·
09,840 shares0
Common Stock
SEC:0001209191-22-006363:0·
€41,2981,875 shares@ €22.02540.0010% mcap38.8% of flow
Common Stock
SEC:0001209191-22-005082·
€41,2981,875 shares@ €22.02540.0010% mcap19.4% of flow
Common Stock
SEC:0001209191-22-005082:0·
€65,1953,058 shares@ €21.31940.0016% mcap61.2% of flow
Common Stock
SEC:0001209191-21-059353·
€65,1953,058 shares@ €21.31940.0016% mcap30.6% of flow
Common Stock
SEC:0001209191-21-059353:0·
04,500 shares0
Common Stock
SEC:0001209191-21-052085·
04,500 shares0
Common Stock
SEC:0001209191-21-052085:0·
8 of 8 declarations
About Heerma Peter
Peter Heerma is the Chief Commercial Officer at Travere Therapeutics, Inc. He is responsible for commercial strategy and business development. With experience in the pharmaceutical sector, Peter plays a key role in developing strategies to increase sales and enhance market presence.
